| abstract |
The present invention relates to disorders and diseases associated with or caused by amyloid or amyloid-like proteins, including amyloidosis, a group of abnormalities and disorders associated with amyloid proteins such as Alzheimer's Disease (AD). Methods and compositions for therapeutic and diagnostic uses in the treatment of The present invention provides novel methods and compositions comprising highly specific and highly effective antibodies that have the ability to specifically recognize and bind specific epitopes from the range of β-amyloid proteins. Antibodies made possible by the teachings of the present invention include amyloid plaques, including secondary amyloidosis and age-related amyloidosis, including but not limited to neurological disorders such as Alzheimer's disease (AD), in particular. useful for the treatment of diseases and disorders attributable to or associated with amyloid or amyloid-like proteins, including amyloidosis, a group of diseases and disorders associated with plaque) formation. |